Importance of Clinical Trials in Drug Development

The Pharma Clinical Trials are conducted to test medical interventions, including drugs, cells and other biological products, surgical procedures, radiological procedures, devices, behavioral treatments and preventive care. Clinical trials are conducted on the people who volunteer to participate in the clinical trials.

As the developers design the clinical study, they will consider what they want to accomplish for each clinical research phase and begin the Investigational New Drug Process, a process they must go through before clinical research begins. The ultimate goal of clinical trials in drug development is to bring a new compound with a proven therapeutic effect to the market. All of the phases in clinical trials are governed by strict protocols. They are overseen by many regulatory bodies, from the Food and Drug Administration (FDA) to small Independent Review Boards (IRBs). IRBs are independent medical experts, ethicists, and laypeople. Researchers report periodically to the IRB, outlining contact with patients, the tests conducted, the results recorded, and even the side effects reported. IRBs are accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

Pharmaceutical organizations like Ikris Pharma International, a WHO-GDP-certified organization, provide clinical supplies (like RLDs and medical products) for research and study. Ikris's globally established supplier network enables us to procure, store (according to the specification of the product) and supply the products from all the major pharmaceutical manufacturers and authorized distribution channels.